meglumine has been researched along with Spinal Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Aliev, MA; Beloborodov, VA; Bogdanov, KD; Borisov, VE; Miklichev, AA; Pestryakov, YY; Shepelev, VV; Stepanov, IA; Varganov, MV | 1 |
| Hoekstra, O; Kramer, G; Lavini, C; Marcus, JT; Pieters-den Bos, I | 1 |
| Berlis, A; Klisch, J; Krämer, N; Kubalek, R; Miosczka, H; Schumacher, M | 1 |
| Cianfoni, A; Colosimo, C; Di Lella, GM; Gaudino, S | 1 |
| Mayer, G; Patzak, H | 1 |
| Seeber, E | 1 |
| Grasso, A; Gusso, MI | 1 |
| Mihara, F; Numaguchi, Y; Rigamonti, D; Rothman, MI; Sadato, N; Sato, S | 1 |
| Hardjasudarma, M | 1 |
| Tien, RD | 1 |
| Runge, VM | 1 |
| Beltran, J; Chandnani, V; Kursunoglu-Brahme, S; McGhee, RA | 1 |
| Bravo, S; Krol, G; Sze, G | 1 |
| Baessler, B; Lahl, R | 1 |
5 review(s) available for meglumine and Spinal Diseases
| Article | Year |
|---|---|
Topics: Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antioxidants; Chronic Disease; Humans; Infusions, Intravenous; Meglumine; Negative-Pressure Wound Therapy; Powders; Preoperative Care; Randomized Controlled Trials as Topic; Skin Transplantation; Spinal Diseases; Spine; Succinates; Surgical Wound Infection; Transplantation, Autologous; Vancomycin; Wound Healing; Wounds and Injuries | 2020 |
Contrast-enhanced MR imaging of the spine: when, why and how? How to optimize contrast protocols in MR imaging of the spine.
Topics: Contrast Media; Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Spinal Diseases | 2006 |
Gadopentetate dimeglumine in craniospinal magnetic resonance imaging: common uses and some potential pitfalls.
Topics: Adult; Brain Diseases; Child; Contrast Media; Drug Combinations; Gadolinium DTPA; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Spinal Cord Diseases; Spinal Diseases | 1992 |
Fat-suppression MR imaging in neuroradiology: techniques and clinical application.
Topics: Adipose Tissue; Artifacts; Contrast Media; Cranial Nerve Diseases; Drug Combinations; Gadolinium DTPA; Head and Neck Neoplasms; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Nervous System Diseases; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Spinal Diseases | 1992 |
Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.
Topics: Bone Diseases; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Joint Diseases; Magnetic Resonance Imaging; Meglumine; Muscular Diseases; Organometallic Compounds; Pentetic Acid; Soft Tissue Neoplasms; Spinal Diseases | 1991 |
9 other study(ies) available for meglumine and Spinal Diseases
| Article | Year |
|---|---|
MRI protocol optimization for quantitative DCE-MRI of the spine.
Topics: Algorithms; Artifacts; Contrast Media; Evaluation Studies as Topic; Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Sensitivity and Specificity; Spinal Diseases; Spine | 2017 |
Intrathecal gadolinium-enhanced MR-cisternography: depiction of the subarachnoidal space and evaluation of gadobenat-dimeglumin-(Gd-BOPTA, "Multihance") toxicity in an animal model and a clinical case.
Topics: Animals; Cerebrospinal Fluid Rhinorrhea; Contrast Media; Cysts; Female; Humans; Injections, Spinal; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Rabbits; Spinal Diseases | 2002 |
[Experience with Dimer-X myelography].
Topics: Adult; Female; Humans; Iothalamic Acid; Lumbar Vertebrae; Male; Meglumine; Myelography; Sorbitol; Spinal Diseases | 1981 |
[Complications and diagnostic value of Dimer-X myelography].
Topics: Aged; Female; Humans; Intervertebral Disc Displacement; Iothalamic Acid; Male; Meglumine; Myelography; Sorbitol; Spinal Diseases | 1981 |
[Analysis of the symptomatological findings after sacculo-radiculography with Dimer-X (clinico-statistical study of 100 consecutive cases].
Topics: Adolescent; Adult; Aged; Confusion; Contrast Media; Diplopia; Female; Headache; Humans; Iothalamic Acid; Male; Meglumine; Middle Aged; Nausea; Neuralgia; Radiography; Sorbitol; Spinal Diseases; Spinal Nerve Roots; Tinnitus; Vertigo | 1981 |
Spinal epidural abscess: evaluation with gadolinium-enhanced MR imaging.
Topics: Abscess; Adolescent; Adult; Aged; Child; Child, Preschool; Contrast Media; Discitis; Drug Combinations; Epidural Space; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Infant; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Osteomyelitis; Pentetic Acid; Retrospective Studies; Spinal Cord; Spinal Diseases; Staphylococcal Infections; Suppuration | 1993 |
Magnetic resonance imaging contrast agents.
Topics: Abdomen; Animals; Brain Diseases; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Spinal Diseases | 1992 |
Spinal lesions: quantitative and qualitative temporal evolution of gadopentetate dimeglumine enhancement in MR imaging.
Topics: Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Sorbitol; Spinal Cord Diseases; Spinal Cord Neoplasms; Spinal Diseases; Spinal Neoplasms; Time Factors | 1989 |
[Complications following myelography with positive contrast media (Pantopaque, Amipaque). Pathomorphologic findings in 2 fatal cases].
Topics: Aged; Brain; Humans; Iodobenzenes; Iophendylate; Iothalamic Acid; Male; Meglumine; Meningitis; Metrizamide; Middle Aged; Myelitis; Myelography; Sorbitol; Spinal Cord; Spinal Diseases | 1985 |